# Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/advancements-and-obstacles-of-crispr-cas9-technology-in-translational-research/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Liting You,Ruizhan Tong,Mengqian Li,Yuncong Liu,Jianxin Xue,You Lü |
| Citations | 113 |
| DOI | 10.1016/j.omtm.2019.02.008 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.cell.com/article/S2329050119300282/pdf |
| OpenAlex ID | https://openalex.org/W2921422175 |
| PMID | 30989086 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Jianxin Xue](https://scholariq.org/researchers/jianxin-xue/)

## Paper journal

- [Molecular Therapy — Methods & Clinical Development](https://scholariq.org/journals/molecular-therapy-methods-and-clinical-development/)

## Paper primary topic

- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)

## Paper topics

- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.